IS4529A - Aðferð til framleiðslu á 4,10-díasetoxý-2alfa-bensóýloxý-5beta, 20-epoxý-1,7beta-díhýdroxý-9-oxó-tax-11-en-13alfa-ýl(2R,3S)-3-bensóýlamínó-2-hýdroxý-3-fenýlprópíónat tríhýdrat - Google Patents

Aðferð til framleiðslu á 4,10-díasetoxý-2alfa-bensóýloxý-5beta, 20-epoxý-1,7beta-díhýdroxý-9-oxó-tax-11-en-13alfa-ýl(2R,3S)-3-bensóýlamínó-2-hýdroxý-3-fenýlprópíónat tríhýdrat

Info

Publication number
IS4529A
IS4529A IS4529A IS4529A IS4529A IS 4529 A IS4529 A IS 4529A IS 4529 A IS4529 A IS 4529A IS 4529 A IS4529 A IS 4529A IS 4529 A IS4529 A IS 4529A
Authority
IS
Iceland
Prior art keywords
diazethoxy
13alfa
2alfa
5beta
7beta
Prior art date
Application number
IS4529A
Other languages
English (en)
Other versions
IS2033B (is
Inventor
Authelin Jean-René
Didier Eric
Leveiller Franck
Taillepied Isabelle
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of IS4529A publication Critical patent/IS4529A/is
Publication of IS2033B publication Critical patent/IS2033B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS4529A 1995-01-25 1997-07-22 Aðferð til framleiðslu á 4,10-díasetoxý-2alfa-bensóýloxý-5beta, 20-epoxý-1,7beta-díhýdroxý-9-oxó-tax-11-en-13alfa-ýl(2R,3S)-3-bensóýlamínó-2-hýdroxý-3-fenýlprópíónat tríhýdrat IS2033B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9500816A FR2729666A1 (fr) 1995-01-25 1995-01-25 Procede de preparation du trihydrate du (2r, 3s)- benzoylamino-2-hydroxy-3-phenylpropionate de 4,10-diacetoxy- 2alpha-benzoyloxy-5beta,20-epoxy-1,7beta-dihydroxy-9-oxo- tax-11-en-13alpha-yle
PCT/FR1996/000104 WO1996022984A1 (fr) 1995-01-25 1996-01-23 PROCEDE DE PREPARATION DU TRIHYDRATE DU (2R,3S)-3-BENZOYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4,10-DIACETOXY-2α-BENZOYLOXY-5β,20-EPOXY-1,7β-DIHYDROXY-9-OXO-TAX-11-EN-13α-YLE

Publications (2)

Publication Number Publication Date
IS4529A true IS4529A (is) 1997-07-22
IS2033B IS2033B (is) 2005-08-15

Family

ID=9475464

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4529A IS2033B (is) 1995-01-25 1997-07-22 Aðferð til framleiðslu á 4,10-díasetoxý-2alfa-bensóýloxý-5beta, 20-epoxý-1,7beta-díhýdroxý-9-oxó-tax-11-en-13alfa-ýl(2R,3S)-3-bensóýlamínó-2-hýdroxý-3-fenýlprópíónat tríhýdrat

Country Status (43)

Country Link
US (1) US6002022A (is)
EP (1) EP0805806B1 (is)
JP (1) JP3782449B2 (is)
KR (1) KR100384773B1 (is)
CN (1) CN1067997C (is)
AP (1) AP750A (is)
AT (1) ATE187719T1 (is)
AU (1) AU707603B2 (is)
BG (1) BG62769B1 (is)
BR (1) BR9606853A (is)
CO (1) CO4700286A1 (is)
CZ (1) CZ287079B6 (is)
DE (1) DE69605651T2 (is)
DK (1) DK0805806T3 (is)
DZ (1) DZ1977A1 (is)
EE (1) EE03396B1 (is)
ES (1) ES2139332T3 (is)
FI (1) FI119245B (is)
FR (1) FR2729666A1 (is)
GE (1) GEP19991833B (is)
GR (1) GR3032110T3 (is)
HU (1) HU223352B1 (is)
IL (1) IL116903A (is)
IN (1) IN184427B (is)
IS (1) IS2033B (is)
MA (1) MA23782A1 (is)
MY (1) MY113230A (is)
NO (1) NO316987B1 (is)
NZ (1) NZ300958A (is)
OA (1) OA10438A (is)
PE (1) PE64896A1 (is)
PL (1) PL183773B1 (is)
PT (1) PT805806E (is)
RO (1) RO115728B1 (is)
RU (1) RU2154642C2 (is)
SK (1) SK281958B6 (is)
TN (1) TNSN96011A1 (is)
TR (1) TR199700676T1 (is)
TW (1) TW356469B (is)
UA (1) UA47420C2 (is)
UY (1) UY24149A1 (is)
WO (1) WO1996022984A1 (is)
ZA (1) ZA96523B (is)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6891050B2 (en) * 2001-08-10 2005-05-10 Dabur India Limited Process for the preparation of taxanes such as paclitaxel, docetaxel and structurally similar analogs
US6881852B2 (en) * 2002-02-05 2005-04-19 Dabur India Limited Process of purification of paclitaxel and docetaxel
US7247738B2 (en) * 2002-05-07 2007-07-24 Dabur India Limited Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids
US6900342B2 (en) * 2002-05-10 2005-05-31 Dabur India Limited Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof
US6838569B2 (en) * 2002-12-16 2005-01-04 Dabur India Limited Process for preparation of paclitaxel trihydrate and docetaxel trihydrate
WO2005061474A1 (en) * 2003-12-12 2005-07-07 Quiral Química Do Brasil Process for the preparation of anhydrous and hydrated active pharmaceutical ingredients (apis); stable pharmaceutical compositions prepared from the same and uses of said compositions
CN100420681C (zh) * 2005-04-29 2008-09-24 上海奥锐特国际贸易有限公司 多烯紫杉醇三水物的制备方法
US20090292131A1 (en) * 2008-05-07 2009-11-26 Ladislav Cvak Processes for preparation of taxanes and intermediates thereof
US8633240B2 (en) * 2012-06-01 2014-01-21 The University Of Utah Research Foundation Paclitaxel trihydrates and methods of making thereof
CN103833693B (zh) * 2014-03-04 2016-02-24 悦康药业集团有限公司 一种紫杉醇化合物及含该紫杉醇化合物的药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994021662A1 (en) * 1993-03-15 1994-09-29 Yale University Diagnosis of human inflammatory bowel diseases and nucleic acid reagents therefor
FR2703049B1 (fr) * 1993-03-22 1995-04-21 Rhone Poulenc Rorer Sa Procédé de purification des taxoïdes.
CA2163837C (en) * 1994-12-13 1999-07-20 Robert K. Perrone Crystalline paclitaxel hydrates

Also Published As

Publication number Publication date
EP0805806B1 (fr) 1999-12-15
MX9705460A (es) 1997-10-31
HUP9801437A1 (hu) 1999-09-28
ZA96523B (en) 1996-10-15
AU4625596A (en) 1996-08-14
SK281958B6 (sk) 2001-09-11
NZ300958A (en) 1999-09-29
US6002022A (en) 1999-12-14
HU223352B1 (hu) 2004-06-28
IL116903A (en) 2003-01-12
IL116903A0 (en) 1996-05-14
UY24149A1 (es) 1996-05-20
SK100897A3 (en) 1998-01-14
IS2033B (is) 2005-08-15
GR3032110T3 (en) 2000-03-31
DK0805806T3 (da) 2000-05-01
ATE187719T1 (de) 2000-01-15
FI973105A0 (fi) 1997-07-24
JP3782449B2 (ja) 2006-06-07
TR199700676T1 (xx) 1998-01-21
PL321493A1 (en) 1997-12-08
KR19980701623A (ko) 1998-06-25
KR100384773B1 (ko) 2003-08-21
TNSN96011A1 (fr) 2005-03-15
BR9606853A (pt) 1997-11-25
NO316987B1 (no) 2004-07-19
UA47420C2 (uk) 2002-07-15
RU2154642C2 (ru) 2000-08-20
BG62769B1 (bg) 2000-07-31
MA23782A1 (fr) 1996-10-01
EE03396B1 (et) 2001-04-16
IN184427B (is) 2000-08-26
CN1067997C (zh) 2001-07-04
OA10438A (fr) 2002-03-22
BG101794A (en) 1998-10-30
ES2139332T3 (es) 2000-02-01
FI119245B (fi) 2008-09-15
PL183773B1 (pl) 2002-07-31
HUP9801437A3 (en) 2001-02-28
FR2729666A1 (fr) 1996-07-26
AU707603B2 (en) 1999-07-15
WO1996022984A1 (fr) 1996-08-01
GEP19991833B (en) 1999-11-05
AP750A (en) 1999-07-06
EE9700157A (et) 1997-12-15
NO973247D0 (no) 1997-07-11
DE69605651D1 (de) 2000-01-20
DE69605651T2 (de) 2000-07-06
CN1169724A (zh) 1998-01-07
CZ236297A3 (en) 1997-11-12
FI973105A (fi) 1997-07-24
MY113230A (en) 2001-12-31
JPH10512871A (ja) 1998-12-08
FR2729666B1 (is) 1997-02-28
TW356469B (en) 1999-04-21
DZ1977A1 (fr) 2002-07-20
CZ287079B6 (en) 2000-08-16
PT805806E (pt) 2000-05-31
CO4700286A1 (es) 1998-12-29
AP9701035A0 (en) 1997-07-31
RO115728B1 (ro) 2000-05-30
PE64896A1 (es) 1997-02-23
EP0805806A1 (fr) 1997-11-12
NO973247L (no) 1997-07-11

Similar Documents

Publication Publication Date Title
NO981800L (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
HUP9600549A3 (en) N-(3-benzofuranyl)urea-derivatives, medicaments containing the same and process for producing them
DE69016821D1 (de) Behandlungsmittel gegen Osteoarthritis.
IS4529A (is) Aðferð til framleiðslu á 4,10-díasetoxý-2alfa-bensóýloxý-5beta, 20-epoxý-1,7beta-díhýdroxý-9-oxó-tax-11-en-13alfa-ýl(2R,3S)-3-bensóýlamínó-2-hýdroxý-3-fenýlprópíónat tríhýdrat
DE59609043D1 (de) Feste Lösungen von 1,4-Diketopyrrolopyrrolen
ZA961884B (en) Novel naphthyl pharmaceutical compounds.
FI934748A0 (fi) Foerfarande foer framstaellning av l-5-(2-acetoxipropionylamino)-2,4,6-trijod-isoftalsyradiklorid
DK0378455T3 (da) Fremgangsmåde til fremstilling af derivater af (+)-(2S,3S)-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-5H-1,5-benzothiazepine-4-on
FI101472B1 (fi) Menetelmä 1,3-diolien monoesterien valmistamiseksi
NO985535D0 (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
TR199700863A3 (tr) Paklitaksel hazirlama prosesi.
ZA9610589B (en) Pharmaceutical compounds.
NO903712D0 (no) Fremgangsmaate for bryting av emulsjoner.
FI924881A (fi) Foerfarande foer framstaellning av (2R, 3E)-4-halo-3-buten-2-oler
NO894623L (no) Biologisk fremgangsmaate for bleking av pulp.
SI0805806T1 (en) Method for preparing 4,10-diacetoxy-2alfa-benzoyloxy-5beta,20-epoxy-1,7beta-dihydroxy-9-oxo-tax-11-en-13alfa-yl (2r,3s)-3-benzoylamino-2-hydroxy-3-phenylpropionate trihydrate
DK0876361T3 (da) 4,10beta-diacetoxy-2alfa-benzoyloxy-5beta,20-epoxy-1-hydroxy-9-oxo-19-norcyclopropa[g]tax-11-en-13alfa-yl-(2R,3S)-3-tert.butoxycarbonylamino-2-hydroxy-3-phenylpropionat-dihydrat og fremgangsmåde til dets fremstilling
FR2736635B1 (fr) Procede de preparation d'alpha,omega-bromochloroalcanes
NO982085L (no) Fremgangsmate for rensing av erytropoietiner.
DK0842135T3 (da) Fremgangsmåde til fremstilling alpha, omega-bromchloralkaner
SE9503711D0 (sv) New pharmaceutical carrier
FI953158A0 (fi) Foerfarande foer biologisk rening av vatten, saerskilt foer minskning av kvaevehalten
FIU950078U0 (fi) Verktyg foer boejning av en flaens
SE9503757D0 (sv) Process for the production of ranitidine